The Asia Pacific Cancer tissue diagnostics market is expected to reach US$ 730.09 Mn in 2027 from US$ 410.78 Mn in 2018. The market is estimated to grow with a CAGR of 6.9% from 2019-2027.
The growth of the market is driven by factors such as the rising number of cancer patients in the Asia Pacific and technological advancements and product launches in Asian countries whereas the lack of resources and awareness for cancer screening and treatment in poor/ less developed countries is likely to have a negative impact on the growth of the Cancer Tissue Diagnostics market in the coming years.Developing countries in Asia have limited or fewer healthcare resources and hence use different strategies to diagnose different types of cancer. In developing poor countries, most of the population relies on the public healthcare systems as the healthcare infrastructures are poor in these countries. Despite advancements in the pharmaceuticals and treatment procedures, cancer is diagnosed in the advanced stages in developing countries as early detection or diagnosis, and treatment is not efficiently promoted.
Many of the low- and middle-income countries (LMICs) in Asia have very poor healthcare services, and the cancer burden is substantial in these countries. Despite the increasing burden of cancer, the disease is still a low priority in healthcare planning and expenditure in most of the Asian LMICs.
Furthermore, South Asian women show lower uptake of breast screening services, especially those from lower socioeconomic groups. Screening rates are low in South Asian populations because they have poor knowledge and awareness of cancer, low community awareness, poor communication between patients and healthcare professionals, and limited access to cancer health services. Thus cancer mortality is high in LMICs as compared with high-income countries (HICs).
There has been rise in cancer incidence and mortality rates in China, making cancer the leading cause of death since 2010 in the country. Much of the rising burden is due to population growth, aging population, and socio-demographic changes. As per data revealed by the WHO, an approximate 4.3 million new cases of cancer were detected as well as 2.9 million cancer deaths were recorded in the country during the year 2018. The prevalence of cancer, coupled with various technological advancements for detection is anticipated to fuel the growth of the market in China during the forecast period.
Rest of Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC CANCER TISSUE DIAGNOSTICS – MARKET SEGMENTATION
By Test Type
- Immunohistochemical Tests
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Stomach Cancer
- Others
- In Situ Hybridization Tests
- Breast Cancer
- Lung Cancer
- Bladder Cancer
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
Companies Mentioned
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher Corporation
- Abcam plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Asia Pacific Cancer Tissue Diagnostics Market – Key Takeaways
3. Asia Pacific Cancer Tissue Diagnostics Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Asia Pacific Cancer Tissue Diagnostics Market – By Test Type
3.2.2 Asia Pacific Cancer Tissue Diagnostics Market – By Country
3.3 PEST Analysis
3.4 Expert Opinions
4. Asia Pacific Cancer Tissue Diagnostics Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Number of Cancer Patients In Asia Pacific
4.1.2 Technological Advancements and Product Launches in Asian Countries
4.2 Key Market Restraints
4.2.1 Lack Of Resources and Awareness For Cancer Screening And Treatment in Poor/ Less Developed Countries
4.3 Key Market Opportunities
4.3.1 Emerging Countries in Asia Pacific Region
4.4 Future Trends
4.4.1 Growing Trend of Personalized Medicine
4.5 Impact Analysis Of Drivers And Restraints
5. Cancer Tissue Diagnostics Market – Asia Pacific Analysis
5.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue Forecasts And Analysis
5.2 Performance of Key Players
6. Asia Pacific Cancer Tissue Diagnostics Market Analysis– by Test Type
6.1 Overview
6.2 Asia Pacific Cancer Tissue Diagnostics Market, By Test Type 2018 & 2027 (%)
6.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts To 2027, By Type Of Fitting (Us$ Mn)
6.4 Immunohistochemical Tests Market
6.4.1 Overview
6.4.2 Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 Breast Cancer Market
6.4.3.1 Overview
6.4.3.2 Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.4 Colorectal Cancer Market
6.4.4.1 Overview
6.4.4.2 Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.5 Prostate Cancer Market
6.4.5.1 Overview
6.4.5.2 Asia Pacific Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.6 Stomach Cancer Market
6.4.6.1 Overview
6.4.6.2 Asia Pacific Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.7 Others Market
6.4.7.1 Overview
6.4.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 In Situ Hybridization Tests Market
6.5.1 Overview
6.5.2 Asia Pacific In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.3 Breast Cancer Market
6.5.3.1 Overview
6.5.3.2 Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.4 Lung Cancer Market
6.5.4.1 Overview
6.5.4.2 Asia Pacific Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.5 Bladder Cancer Market
6.5.5.1 Overview
6.5.5.2 Asia Pacific Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
6.5.6 Others Market
6.5.6.1 Overview
6.5.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
7. Asia Pacific Cancer Tissue Diagnostics Market
7.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027
7.1.1 Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.2 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.2.1 Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.2.2 Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.3 Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
7.1.4 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.1 Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.4.2 Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.4.2.1 Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.4.2.2 Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.1 China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.5.2 China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.5.2.1 China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.5.2.2 China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.1 India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.6.2 India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.6.2.1 India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.6.2.2 India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.1 South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.7.2 South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.7.2.1 South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.7.2.2 South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.1 Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.1.8.2 Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
7.1.8.2.1 Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
7.1.8.2.2 Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8. Cancer Tissue Diagnostics Market– Industry Landscape
8.1 Overview
8.2 Growth Strategies In The Cancer Tissue Diagnostics Market, 2016-2019
8.3 Organic Growth Strategies
8.3.1 Overview
8.4 Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.4.1 Product Launches
8.4.1.1 Recent Product Launches By Players In The Cancer Tissue Diagnostics Market
8.4.2 Product Approvals
8.4.2.1 Recent Product Approvals By Players In The Cancer Tissue Diagnostics Market
8.4.3 Expansion & Other Activities
8.4.3.1 Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
8.4.4 Product Enhancements
8.4.4.1 Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
8.5 Inorganic Growth Strategies
8.5.1 Overview
8.6 Inorganic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
8.6.1 Agreements
8.6.1.1 Recent Agreements By Players In The Cancer Tissue Diagnostics Market
8.6.2 Partnerships & Collaborations
8.6.2.1 Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
8.6.3 Acquisitions
8.6.3.1 Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
9. Cancer Tissue Diagnostics Market–Key Company Profiles
9.1 Bio-Rad Laboratories, Inc.
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Financial Information
9.1.4 Product Portfolio
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Financial Information
9.2.4 Product Portfolio
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Financial Overview
9.3.4 Product Portfolio
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Abbott
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Financial Overview
9.4.4 Product Portfolio
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Enzo Biochem Inc.
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Financial Overview
9.5.4 Product Portfolio
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 Agilent Technologies, Inc.
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Financial Overview
9.6.4 Product Portfolio
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Cancer Genetics Inc.
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Financial Overview
9.7.4 Product Portfolio
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Merck Kgaa (Sigma-Aldrich)
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Financial Overview
9.8.4 Product Portfolio
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Abcam Plc.
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Financial Overview
9.9.4 Product Portfolio
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Danaher
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Financial Information
9.10.4 Product Portfolio
9.10.5 SWOT Analysis
9.10.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary Of Terms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Primary Research
LIST OF TABLES
Table 1. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2025, By Test Type (US$ Mn)
Table 2. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 3. Asia Pacific Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 4. Asia Pacific In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 5. Japan Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 6. Japan Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 7. Japan In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 8. China Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 9. China Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 10. China In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 11. India Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 12. India Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 13. India In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 14. South Korea Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 15. South Korea Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 16. South Korea In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 17. Australia Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Test Type (US$ Mn)
Table 18. Australia Immunohistochemical Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 19. Australia In Situ Hybridization Tests Market Revenue And Forecasts to 2027, By Type (US$ Mn)
Table 20. Recent Product Launches in the Cancer Tissue Diagnostics Market
Table 21. Recent product Approvals in the Cancer Tissue Diagnostics Market
Table 22. Recent Expansion & Other Activities By Players In The Cancer Tissue Diagnostics Market
Table 23. Recent Product Enhancements By Players In The Cancer Tissue Diagnostics Market
Table 24. Recent Agreements By Players In The Cancer Tissue Diagnostics Market
Table 25. Recent Partnerships & Collaborations By Players In The Cancer Tissue Diagnostics Market
Table 26. Recent Acquisitions By Players In The Cancer Tissue Diagnostics Market
Table 27. Glossary of Terms, Cancer Tissue Diagnostics Market
LIST OF FIGURES
Figure 1. China Cancer Tissue Diagnostics Market, Revenue (US$ Mn), By 2018 & 2027
Figure 2. Global Cancer Tissue Diagnostics Market By Test Type, Market Share (%), 2018
Figure 3. Cancer Tissue Diagnostics Market Segmentation
Figure 4. Asia - Pacific: PEST Analysis
Figure 5. Cancer Tissue Diagnostics Market Impact Analysis Of Driver And Restraint
Figure 6. Asia Pacific Cancer Tissue Diagnostics Market – Revenue Forecasts And Analysis – 2017- 2027
Figure 7. Prominent Players in the Cancer Tissue Diagnostics Market
Figure 8. Asia Pacific Cancer Tissue Diagnostics Market, by Test Type 2018 & 2027 (%)
Figure 9. Asia Pacific Immunohistochemical Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 10. Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Prostate Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Stomach Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific In Situ Hybridization Tests Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Breast Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Lung Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Bladder Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Cancer Tissue Diagnostics Market Revenue Overview, by Country, 2018 (US$ MN)
Figure 21. Asia Pacific Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia Pacific Cancer Tissue Diagnostics Market Revenue And Forecasts to 2027, By Country (%)
Figure 23. Japan Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. China Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. India Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. South Korea Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Australia Cancer Tissue Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019
Figure 29. Organic Growth Strategies in the Cancer Tissue Diagnostics Market, 2016-2019 (%)
Figure 30. Inorganic Developments in the Cancer Tissue Diagnostics Market, 2016-2019(%)
The List of Companies - Asia Pacific Cancer Tissue Diagnostics Market
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Bio Rad Laboratories Inc.
- Abbott
- Enzo Life Sciences, Inc.
- Agilent Technologies, Inc.
- Cancer Genetics Inc.
- Merck KGaA (Sigma-Aldrich Co. LLC)
- Danaher Corporation
- Abcam plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Cancer Tissue Diagnostics Market
Jan 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jan 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jan 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jan 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jan 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Jan 2020